These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38116721)

  • 1. Maternal immunization in women living with HIV.
    Dauby N; Gagneux-Brunon A; Martin C; Mussi-Pinhata MM; Goetghebuer T
    AIDS; 2024 Feb; 38(2):137-144. PubMed ID: 38116721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-related immune activation attenuates polyfunctional IgG and memory B-cell responses to Tdap immunization during pregnancy.
    Taton M; Willems F; Widomski C; Georges D; Martin C; Jiang Y; Renard K; Konopnicki D; Cogan A; Necsoi C; Matagne A; De Wit S; Ackerman ME; Marchant A; Dauby N
    EBioMedicine; 2024 Jun; 104():105179. PubMed ID: 38848615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious morbidity of breastfed, HIV-exposed uninfected infants under conditions of universal antiretroviral therapy in South Africa: a prospective cohort study.
    le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Zerbe A; le Roux DM; Kroon M; Myer L
    Lancet Child Adolesc Health; 2020 Mar; 4(3):220-231. PubMed ID: 31932246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial.
    Heyderman RS; Madhi SA; French N; Cutland C; Ngwira B; Kayambo D; Mboizi R; Koen A; Jose L; Olugbosi M; Wittke F; Slobod K; Dull PM
    Lancet Infect Dis; 2016 May; 16(5):546-555. PubMed ID: 26869376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial.
    Bebia Z; Reyes O; Jeanfreau R; Kantele A; De Leon RG; Sánchez MG; Banooni P; Gardener GJ; Rasero JLB; Pardilla MBE; Langley JM; Di Leo CM; Botelho-Nevers E; Buttery J; Laurichesse H; Madhi SA; García AM; Stanley T; Barjat T; Griffith R; Castrejón-Alba MM; de Heusch M; Dieussaert I; Hercor M; Lese P; Qian H; Tullio AN; Henry O
    J Infect Dis; 2023 Aug; 228(3):299-310. PubMed ID: 36722147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal immunization.
    Chu HY; Englund JA
    Birth Defects Res; 2017 Mar; 109(5):379-386. PubMed ID: 28398678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Maternal Immunization With 10-Valent Pneumococcus Conjugate Vaccine (PCV-10), 23-Valent Pneumococcus Polysaccharide Vaccine, or Placebo on the Immunogenicity of PCV-10 in Human Immunodeficiency Virus-Exposed Uninfected Infants: A Randomized Clinical Trial.
    Mussi-Pinhata MM; Ward S; Laimon L; Pelton SI; Canniff J; Golner A; Bone F; Newton L; Muresan P; Fenton T; Johnson MJ; João EC; Santos BR; Pilotto JH; Oliveira RH; Pinto JA; Dal Bó AGBL; Kreitchmann R; Chakhtoura N; Duarte G; Weinberg A
    Clin Infect Dis; 2022 Sep; 75(6):996-1005. PubMed ID: 35037049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired haemophilus influenzae type b transplacental antibody transmission and declining antibody avidity through the first year of life represent potential vulnerabilities for HIV-exposed but -uninfected infants.
    Gaensbauer JT; Rakhola JT; Onyango-Makumbi C; Mubiru M; Westcott JE; Krebs NF; Asturias EJ; Fowler MG; McFarland E; Janoff EN
    Clin Vaccine Immunol; 2014 Dec; 21(12):1661-7. PubMed ID: 25298109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal immunization: trends in South and Southeast Asian countries.
    Kamath GD; Kukreja S; Mukherjee P; Kolhapure S; Sathyanarayanan S
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8372-8381. PubMed ID: 34517746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life.
    Reikie BA; Naidoo S; Ruck CE; Slogrove AL; de Beer C; la Grange H; Adams RC; Ho K; Smolen K; Speert DP; Cotton MF; Preiser W; Esser M; Kollmann TR
    Clin Vaccine Immunol; 2013 Jan; 20(1):33-8. PubMed ID: 23114697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental Transfer of Respiratory Syncytial Virus Antibody Among HIV-Exposed, Uninfected Infants.
    Patel SM; Jallow S; Boiditswe S; Madhi SA; Feemster KA; Steenhoff AP; Arscott-Mills T; Muthoga C; Ajibola G; Shapiro R; Shah SS; Cunningham CK; Kelly MS
    J Pediatric Infect Dis Soc; 2020 Jul; 9(3):349-356. PubMed ID: 31549157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience and challenges on influenza and pertussis vaccination in pregnant women.
    Madhi SA; Nunes MC
    Hum Vaccin Immunother; 2018; 14(9):2183-2188. PubMed ID: 30024822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal immunization: where are we now and how to move forward?
    Vojtek I; Dieussaert I; Doherty TM; Franck V; Hanssens L; Miller J; Bekkat-Berkani R; Kandeil W; Prado-Cohrs D; Vyse A
    Ann Med; 2018 May; 50(3):193-208. PubMed ID: 29308916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization during pregnancy.
    Loubet P; Anselem O; Launay O
    Expert Rev Vaccines; 2018 May; 17(5):383-393. PubMed ID: 29715051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological factors that may impair transplacental transfer of RSV antibodies: Implications for maternal immunization policy and research priorities for low- and middle-income countries.
    Atwell JE; Lutz CS; Sparrow EG; Feikin DR
    Vaccine; 2022 Jul; 40(32):4361-4370. PubMed ID: 35725783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal immunisation to improve the health of HIV-exposed infants.
    Bengtson AM; Sanfilippo AM; Hughes BL; Savitz DA
    Lancet Infect Dis; 2019 Apr; 19(4):e120-e131. PubMed ID: 30529212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Risk of Group B
    Dauby N; Chamekh M; Melin P; Slogrove AL; Goetghebuer T
    Front Immunol; 2016; 7():505. PubMed ID: 27899925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Maternal Pertussis Immunization on Infant Vaccine Responses to a Booster Pertussis-Containing Vaccine in Vietnam.
    Maertens K; Hoang TT; Nguyen TD; Caboré RN; Duong TH; Huygen K; Hens N; Van Damme P; Dang DA; Leuridan E
    Clin Infect Dis; 2016 Dec; 63(suppl 4):S197-S204. PubMed ID: 27838673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of intentions to get vaccinated against influenza, COVID 19, pertussis and to get a future vaccine against respiratory syncytial virus in pregnant women.
    Cubizolles C; Barjat T; Chauleur C; Bruel S; Botelho-Nevers E; Gagneux-Brunon A
    Vaccine; 2023 Nov; 41(49):7342-7347. PubMed ID: 37957038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants.
    Kidzeru EB; Hesseling AC; Passmore JA; Myer L; Gamieldien H; Tchakoute CT; Gray CM; Sodora DL; Jaspan HB
    AIDS; 2014 Jun; 28(10):1421-30. PubMed ID: 24785950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.